Literature DB >> 22962879

Evaluation and management of galactorrhea.

Wenyu Huang1, Mark E Molitch.   

Abstract

Galactorrhea is commonly caused by hyperprolactinemia, especially when it is associated with amenorrhea. Hyperprolactinemia is most often induced by medication or associated with pituitary adenomas or other sellar or suprasellar lesions. Less common causes of galactorrhea include hypothyroidism, renal insufficiency, pregnancy, and nipple stimulation. After pathologic nipple discharge is ruled out, patients with galactorrhea should be evaluated by measurement of their prolactin level. Those with hyperprolactinemia should have pregnancy ruled out, and thyroid and renal function assessed. Brain magnetic resonance imaging should be performed if no other cause of hyperprolactinemia is found. Patients with prolactinomas are usually treated with dopamine agonists (bromocriptine or cabergoline); surgery or radiation therapy is rarely required. Medications causing hyperprolactinemia should be discontinued or replaced with a medication from a similar class with lower potential for causing hyperprolactinemia. Normoprolactinemic patients with idiopathic, nonbothersome galactorrhea can be reassured and do not need treatment; however, those with bothersome galactorrhea usually respond to a short course of a low-dose dopamine agonist.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22962879

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  7 in total

Review 1.  Hyperprolactinaemia.

Authors:  Irene Samperi; Kirstie Lithgow; Niki Karavitaki
Journal:  J Clin Med       Date:  2019-12-13       Impact factor: 4.241

2.  Italian Association of Clinical Endocrinologists (AME) and International Chapter of Clinical Endocrinology (ICCE). Position statement for clinical practice: prolactin-secreting tumors.

Authors:  Renato Cozzi; Maria Rosaria Ambrosio; Roberto Attanasio; Claudia Battista; Alessandro Bozzao; Marco Caputo; Enrica Ciccarelli; Laura De Marinis; Ernesto De Menis; Marco Faustini Fustini; Franco Grimaldi; Andrea Lania; Giovanni Lasio; Francesco Logoluso; Marco Losa; Pietro Maffei; Davide Milani; Maurizio Poggi; Michele Zini; Laurence Katznelson; Anton Luger; Catalina Poiana
Journal:  Eur J Endocrinol       Date:  2022-02-03       Impact factor: 6.664

3.  Author's Reply: The curious case of prolactin hormone.

Authors:  Mohammad Abid Keen; Iffat Hassan
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

4.  Hyperprolactinemia Secondary to Allergic Fungal Sinusitis Compressing the Pituitary Gland.

Authors:  Nikita Chapurin; Cynthia Wang; David M Steinberg; David W Jang
Journal:  Case Rep Otolaryngol       Date:  2016-02-21

5.  Etiological Profile of Galactorrhoea.

Authors:  Sridevi Atluri; Vijaya Sarathi; Amit Goel; Rakesh Boppana; C Shivaprasad
Journal:  Indian J Endocrinol Metab       Date:  2018 Jul-Aug

Review 6.  Nipple discharge: The state of the art.

Authors:  Giovanna Panzironi; Federica Pediconi; Francesco Sardanelli
Journal:  BJR Open       Date:  2018-11-07

7.  Omeprazole-induced galactorrhea in kidney transplant patients-a case report.

Authors:  Choki Dorji; Farruk Ahammed Robin; Kesara Na-Bangchang
Journal:  J Med Case Rep       Date:  2022-03-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.